NEWS & UPDATE
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021
Sep 17, 2021 — 4 min read
NEWS & UPDATE
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021
Sep 17, 2021 — 4 min read
NEWS & UPDATE
Lunit AI Receives HSA Approval, Now Commercially Available in Singapore
Sep 6, 2021 — 2 min read
NEWS & UPDATE
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis
Aug 19, 2021 — 3 min read
NEWS & UPDATE
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
Aug 12, 2021 — 3 min read
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Lunit Secures $26M Investment from Guardant Health in a Strategic Funding Round
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
Lunit Announces Partnership to Incorporate its Chest Detection Suite into Philips' Diagnostic X-ray Suite
Logo System
Lunit LogoAll LogosCompany Introduction
EN - Lunit IntroductionKR - Lunit IntroductionProducts Image
Lunit INSIGHTLunit SCOPE